0.007900 0.000000 0.000000 0.000000 0.007900 0.000000 0.000000 0.000000 0.009879 0.00000 0.00000 0.00000 Gallop, J.L. Kent, H.M. Mcmahon, H.T. Evans, P.R. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 8 90.00 90.00 90.00 126.578 126.578 101.226 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 Se 196.106 n SELENOMETHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking UK Embo J. EMJODG 0897 0261-4189 25 2898 10.1038/SJ.EMBOJ.7601174 16763559 Mechanism of Endophilin N-Bar Domain-Mediated Membrane Curvature. 2006 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 100.0 1 CCD 2004-11-05 ADSC CCD MAD M x-ray 1 0.98 1.0 ID29 ESRF 0.98 SYNCHROTRON ESRF BEAMLINE ID29 24025.070 SH3-CONTAINING GRB2-LIKE PROTEIN 2 2.3.1.- BAR DOMAIN, RESIDUES 1-143 1 man polymer ENDOPHILIN A1, SH3 DOMAIN PROTEIN 2A, SH3P4 no yes EGTKLDDDFKE(MSE)ERKVDVTSRAV(MSE)EI(MSE)TKTIEYLQPNPASRAKPQAEALLAEA(MSE)LKFGRELGDD CNFGPALGEVGEA(MSE)RELSEVKDSLD(MSE)EVKQNFIDPLQNLHDKDLREIQHHLKKLEGRRLDFDYKKKRQGKIP DEELRQALEKFDESKEIAESS(MSE)FNLLE(MSE)DIEQVSQLSALVQAQLEYHKQAVQILQQVTVRLEERIRQA EGTKLDDDFKEMERKVDVTSRAVMEIMTKTIEYLQPNPASRAKPQAEALLAEAMLKFGRELGDDCNFGPALGEVGEAMRE LSEVKDSLDMEVKQNFIDPLQNLHDKDLREIQHHLKKLEGRRLDFDYKKKRQGKIPDEELRQALEKFDESKEIAESSMFN LLEMDIEQVSQLSALVQAQLEYHKQAVQILQQVTVRLEERIRQA A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n RAT sample 10116 RATTUS NORVEGICUS 511693 ESCHERICHIA COLI BL21 PLASMID 1 8.76 85.85 8.00 25% BUTANE-1,4-DIOL, 100MM TRIS PH 8.0,4DEGC, CRYOPROTECTED IN 40% BUTANE-1,4-DIOL, 25% ETHYLENE GLYCOL 277 exptl_crystal_grow pdbx_database_proc pdbx_database_status struct_biol struct_conn repository Initial release Version format compliance Version format compliance Data collection Derived calculations Experimental preparation Other 1 0 2006-06-14 1 1 2011-05-08 1 2 2011-07-13 1 3 2019-05-29 _exptl_crystal_grow.temp _pdbx_database_status.recvd_author_approval _struct_conn.pdbx_leaving_atom_flag PDBE Y PDBE 2005-08-26 REL UNIPROT DOES NOT CURRENTLY HAVE A FULL-LENGTH ENTRY FOR RAT ENDOPHILIN A1. THE FRAGMENTS FROM 25-104 HAS BEEN MAPPED TO ITSELF AT THE PRESENT TIME DUE TO A LACK OF AVAILABLE SEQUENCE DATABASE MAPPING GLU 25 n 1 GLU 25 A GLY 26 n 2 GLY 26 A THR 27 n 3 THR 27 A LYS 28 n 4 LYS 28 A LEU 29 n 5 LEU 29 A ASP 30 n 6 ASP 30 A ASP 31 n 7 ASP 31 A ASP 32 n 8 ASP 32 A PHE 33 n 9 PHE 33 A LYS 34 n 10 LYS 34 A GLU 35 n 11 GLU 35 A MSE 36 n 12 MSE 36 A GLU 37 n 13 GLU 37 A ARG 38 n 14 ARG 38 A LYS 39 n 15 LYS 39 A VAL 40 n 16 VAL 40 A ASP 41 n 17 ASP 41 A VAL 42 n 18 VAL 42 A THR 43 n 19 THR 43 A SER 44 n 20 SER 44 A ARG 45 n 21 ARG 45 A ALA 46 n 22 ALA 46 A VAL 47 n 23 VAL 47 A MSE 48 n 24 MSE 48 A GLU 49 n 25 GLU 49 A ILE 50 n 26 ILE 50 A MSE 51 n 27 MSE 51 A THR 52 n 28 THR 52 A LYS 53 n 29 LYS 53 A THR 54 n 30 THR 54 A ILE 55 n 31 ILE 55 A GLU 56 n 32 GLU 56 A TYR 57 n 33 TYR 57 A LEU 58 n 34 LEU 58 A GLN 59 n 35 GLN 59 A PRO 60 n 36 PRO 60 A ASN 61 n 37 ASN 61 A PRO 62 n 38 PRO 62 A ALA 63 n 39 ALA 63 A SER 64 n 40 SER 64 A ARG 65 n 41 ARG 65 A ALA 66 n 42 ALA 66 A LYS 67 n 43 LYS 67 A PRO 87 n 44 PRO 87 A GLN 88 n 45 GLN 88 A ALA 89 n 46 ALA 89 A GLU 90 n 47 GLU 90 A ALA 91 n 48 ALA 91 A LEU 92 n 49 LEU 92 A LEU 93 n 50 LEU 93 A ALA 94 n 51 ALA 94 A GLU 95 n 52 GLU 95 A ALA 96 n 53 ALA 96 A MSE 97 n 54 MSE 97 A LEU 98 n 55 LEU 98 A LYS 99 n 56 LYS 99 A PHE 100 n 57 PHE 100 A GLY 101 n 58 GLY 101 A ARG 102 n 59 ARG 102 A GLU 103 n 60 GLU 103 A LEU 104 n 61 LEU 104 A GLY 105 n 62 GLY 105 A ASP 106 n 63 ASP 106 A ASP 107 n 64 ASP 107 A CYS 108 n 65 CYS 108 A ASN 109 n 66 ASN 109 A PHE 110 n 67 PHE 110 A GLY 111 n 68 GLY 111 A PRO 112 n 69 PRO 112 A ALA 113 n 70 ALA 113 A LEU 114 n 71 LEU 114 A GLY 115 n 72 GLY 115 A GLU 116 n 73 GLU 116 A VAL 117 n 74 VAL 117 A GLY 118 n 75 GLY 118 A GLU 119 n 76 GLU 119 A ALA 120 n 77 ALA 120 A MSE 121 n 78 MSE 121 A ARG 122 n 79 ARG 122 A GLU 123 n 80 GLU 123 A LEU 124 n 81 LEU 124 A SER 125 n 82 SER 125 A GLU 126 n 83 GLU 126 A VAL 127 n 84 VAL 127 A LYS 128 n 85 LYS 128 A ASP 129 n 86 ASP 129 A SER 130 n 87 SER 130 A LEU 131 n 88 LEU 131 A ASP 132 n 89 ASP 132 A MSE 133 n 90 MSE 133 A GLU 134 n 91 GLU 134 A VAL 135 n 92 VAL 135 A LYS 136 n 93 LYS 136 A GLN 137 n 94 GLN 137 A ASN 138 n 95 ASN 138 A PHE 139 n 96 PHE 139 A ILE 140 n 97 ILE 140 A ASP 141 n 98 ASP 141 A PRO 142 n 99 PRO 142 A LEU 143 n 100 LEU 143 A GLN 144 n 101 GLN 144 A ASN 145 n 102 ASN 145 A LEU 146 n 103 LEU 146 A HIS 147 n 104 HIS 147 A ASP 148 n 105 ASP 148 A LYS 149 n 106 LYS 149 A ASP 150 n 107 ASP 150 A LEU 151 n 108 LEU 151 A ARG 152 n 109 ARG 152 A GLU 153 n 110 GLU 153 A ILE 154 n 111 ILE 154 A GLN 155 n 112 GLN 155 A HIS 156 n 113 HIS 156 A HIS 157 n 114 HIS 157 A LEU 158 n 115 LEU 158 A LYS 159 n 116 LYS 159 A LYS 160 n 117 LYS 160 A LEU 161 n 118 LEU 161 A GLU 162 n 119 GLU 162 A GLY 163 n 120 GLY 163 A ARG 164 n 121 ARG 164 A ARG 165 n 122 ARG 165 A LEU 166 n 123 LEU 166 A ASP 167 n 124 ASP 167 A PHE 168 n 125 PHE 168 A ASP 169 n 126 ASP 169 A TYR 170 n 127 TYR 170 A LYS 171 n 128 LYS 171 A LYS 172 n 129 LYS 172 A LYS 173 n 130 LYS 173 A ARG 174 n 131 ARG 174 A GLN 175 n 132 GLN 175 A GLY 176 n 133 GLY 176 A LYS 177 n 134 LYS 177 A ILE 178 n 135 ILE 178 A PRO 179 n 136 PRO 179 A ASP 180 n 137 ASP 180 A GLU 181 n 138 GLU 181 A GLU 182 n 139 GLU 182 A LEU 183 n 140 LEU 183 A ARG 184 n 141 ARG 184 A GLN 185 n 142 GLN 185 A ALA 186 n 143 ALA 186 A LEU 187 n 144 LEU 187 A GLU 188 n 145 GLU 188 A LYS 189 n 146 LYS 189 A PHE 190 n 147 PHE 190 A ASP 191 n 148 ASP 191 A GLU 192 n 149 GLU 192 A SER 193 n 150 SER 193 A LYS 194 n 151 LYS 194 A GLU 195 n 152 GLU 195 A ILE 196 n 153 ILE 196 A ALA 197 n 154 ALA 197 A GLU 198 n 155 GLU 198 A SER 199 n 156 SER 199 A SER 200 n 157 SER 200 A MSE 201 n 158 MSE 201 A PHE 202 n 159 PHE 202 A ASN 203 n 160 ASN 203 A LEU 204 n 161 LEU 204 A LEU 205 n 162 LEU 205 A GLU 206 n 163 GLU 206 A MSE 207 n 164 MSE 207 A ASP 208 n 165 ASP 208 A ILE 209 n 166 ILE 209 A GLU 210 n 167 GLU 210 A GLN 211 n 168 GLN 211 A VAL 212 n 169 VAL 212 A SER 213 n 170 SER 213 A GLN 214 n 171 GLN 214 A LEU 215 n 172 LEU 215 A SER 216 n 173 SER 216 A ALA 217 n 174 ALA 217 A LEU 218 n 175 LEU 218 A VAL 219 n 176 VAL 219 A GLN 220 n 177 GLN 220 A ALA 221 n 178 ALA 221 A GLN 222 n 179 GLN 222 A LEU 223 n 180 LEU 223 A GLU 224 n 181 GLU 224 A TYR 225 n 182 TYR 225 A HIS 226 n 183 HIS 226 A LYS 227 n 184 LYS 227 A GLN 228 n 185 GLN 228 A ALA 229 n 186 ALA 229 A VAL 230 n 187 VAL 230 A GLN 231 n 188 GLN 231 A ILE 232 n 189 ILE 232 A LEU 233 n 190 LEU 233 A GLN 234 n 191 GLN 234 A GLN 235 n 192 GLN 235 A VAL 236 n 193 VAL 236 A THR 237 n 194 THR 237 A VAL 238 n 195 VAL 238 A ARG 239 n 196 ARG 239 A LEU 240 n 197 LEU 240 A GLU 241 n 198 GLU 241 A GLU 242 n 199 GLU 242 A ARG 243 n 200 ARG 243 A ILE 244 n 201 ILE 244 A ARG 245 n 202 ARG 245 A GLN 246 n 203 GLN 246 A ALA 247 n 204 ALA 247 A author_and_software_defined_assembly PQS 2 dimeric A MSE 36 SELENOMETHIONINE A MSE 12 MET A MSE 48 SELENOMETHIONINE A MSE 24 MET A MSE 51 SELENOMETHIONINE A MSE 27 MET A MSE 97 SELENOMETHIONINE A MSE 54 MET A MSE 121 SELENOMETHIONINE A MSE 78 MET A MSE 133 SELENOMETHIONINE A MSE 90 MET A MSE 201 SELENOMETHIONINE A MSE 158 MET A MSE 207 SELENOMETHIONINE A MSE 164 MET 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 -1.0000000000 0.0000000000 0.0000000000 0.0000000000 -1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 6_665 -x+1,-y+1,z crystal symmetry operation 126.5780000000 126.5780000000 0.0000000000 1 A A C N LYS PRO 67 87 12.45 1 A LYS 28 65.96 120.54 1 A SER 64 -160.03 71.44 1 A ALA 66 -54.63 103.70 1 A CYS 108 -87.22 -156.50 1 A PHE 139 -134.13 -55.77 1 A ASP 148 -68.91 -81.39 1 A LYS 149 -50.24 -79.52 1 A ARG 174 -91.13 34.64 59.79 0.32000 0.00000 0.00000 0.32000 0.00000 -0.65000 0.881 0.861 HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. 0.295 0.279 0.280 2.90 89.44 904 16875 5.100 99.9 12.411 0.228 RANDOM 1 THROUGHOUT MAD 0.330 0.273 0.80 0.80 1.20 MAXIMUM LIKELIHOODWITH PHASES MASK 2.90 89.44 0 1653 0 0 1653 0.020 0.023 1820 0.956 1.985 2234 4.461 5.000 202 35.810 25.556 90 17.836 15.000 346 14.325 15.000 13 0.072 0.200 245 0.003 0.020 1242 0.235 0.200 708 0.293 0.200 1169 0.128 0.200 23 0.172 0.200 53 0.080 0.200 4 0.595 1.500 1193 0.696 2.000 1629 1.239 3.000 675 1.833 4.500 605 0.3380 0.3610 2.98 65 1235 20 2.900 44.000 2C08 393336 6.000 0.16000 1 19.8000 22.100 99.9 0.95000 2.90 3.06 3.600 1 22.30 100.0 refinement REFMAC 5.2.0005 data reduction MOSFLM data scaling SCALA phasing SHARP SH3-CONTAINING GRB2-LIKE PROTEIN 2 (E.C.2.3.1.-) Rat endophilin A1 BAR domain 1 N N A ASP 30 A ASP 6 HELX_P A GLN 59 A GLN 35 1 1 30 A ASN 61 A ASN 37 HELX_P A ARG 65 A ARG 41 5 2 5 A GLN 88 A GLN 45 HELX_P A GLY 105 A GLY 62 1 3 18 A ASN 109 A ASN 66 HELX_P A PHE 139 A PHE 96 1 4 31 A PHE 139 A PHE 96 HELX_P A ARG 174 A ARG 131 1 5 36 A PRO 179 A PRO 136 HELX_P A GLU 206 A GLU 163 1 6 28 A MSE 207 A MSE 164 HELX_P A GLN 246 A GLN 203 1 7 40 covale 1.327 both A GLU 35 A C GLU 11 1_555 A MSE 36 A N MSE 12 1_555 covale 1.334 both A MSE 36 A C MSE 12 1_555 A GLU 37 A N GLU 13 1_555 covale 1.334 both A VAL 47 A C VAL 23 1_555 A MSE 48 A N MSE 24 1_555 covale 1.332 both A MSE 48 A C MSE 24 1_555 A GLU 49 A N GLU 25 1_555 covale 1.329 both A ILE 50 A C ILE 26 1_555 A MSE 51 A N MSE 27 1_555 covale 1.335 both A MSE 51 A C MSE 27 1_555 A THR 52 A N THR 28 1_555 covale 1.331 both A ALA 96 A C ALA 53 1_555 A MSE 97 A N MSE 54 1_555 covale 1.330 both A MSE 97 A C MSE 54 1_555 A LEU 98 A N LEU 55 1_555 covale 1.336 both A ALA 120 A C ALA 77 1_555 A MSE 121 A N MSE 78 1_555 covale 1.333 both A MSE 121 A C MSE 78 1_555 A ARG 122 A N ARG 79 1_555 covale 1.335 both A ASP 132 A C ASP 89 1_555 A MSE 133 A N MSE 90 1_555 covale 1.330 both A MSE 133 A C MSE 90 1_555 A GLU 134 A N GLU 91 1_555 covale 1.330 both A SER 200 A C SER 157 1_555 A MSE 201 A N MSE 158 1_555 covale 1.330 both A MSE 201 A C MSE 158 1_555 A PHE 202 A N PHE 159 1_555 covale 1.338 both A GLU 206 A C GLU 163 1_555 A MSE 207 A N MSE 164 1_555 covale 1.329 both A MSE 207 A C MSE 164 1_555 A ASP 208 A N ASP 165 1_555 TRANSFERASE ENDOCYTOSIS, BAR DOMAIN, MEMBRANE CURVATURE, SH3 DOMAIN, ACYLTRANSFERASE, COILED COIL, LIPID-BINDING, MULTIGENE FAMILY, PHOSPHORYLATION, TRANSFERASE 2C08 PDB 1 2C08 SH3G2_RAT UNP 1 O35179 25 67 2C08 25 67 2C08 A 1 1 43 87 104 2C08 87 104 2C08 A 1 44 61 1 143 2C08 105 247 O35179 A 2 62 204 80 I 41